Scleroderma News and Research

RSS
Scleroderma is a chronic, often progressive, autoimmune disease in which the body's immune system attacks its own body. The disease, which literally means "hard skin," can cause a thickening and tightening of the skin. In some cases it causes serious damage to internal organs including the lungs, heart, kidneys, esophagus and gastrointestinal tract. Some medicines and treatments can help with certain symptoms, but there is still no cure for scleroderma, which affects about 300,000 nationwide. (By way of comparison, about 50,000 people have muscular dystrophy, 250,000 are estimated to have lupus and 350,000 have multiple sclerosis.)
Researchers find experimental compound to treat fibrotic diseases

Researchers find experimental compound to treat fibrotic diseases

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Improving the Diagnosis of Cardiac Sarcoidosis

Improving the Diagnosis of Cardiac Sarcoidosis

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

Report highlights needs, experiences of people with rare autoimmune rheumatic diseases

Report highlights needs, experiences of people with rare autoimmune rheumatic diseases

ACR receives grant to focus on projects that reduce health disparities

ACR receives grant to focus on projects that reduce health disparities

Study reveals key role of macrophages in systemic sclerosis

Study reveals key role of macrophages in systemic sclerosis

LJI study reveals key player that promotes skin inflammation in atopic dermatitis

LJI study reveals key player that promotes skin inflammation in atopic dermatitis

Stem cell transplant can effectively treat patients with rare autoimmune disease, study shows

Stem cell transplant can effectively treat patients with rare autoimmune disease, study shows

New HSS study may signal hope for patients suffering from scleroderma

New HSS study may signal hope for patients suffering from scleroderma

Stem cell transplant improves survival among scleroderma patients

Stem cell transplant improves survival among scleroderma patients

African-American women with a common form of hair loss linked to greater risk for uterine fibroids

African-American women with a common form of hair loss linked to greater risk for uterine fibroids

Newly discovered drug-like compound may revolutionize treatment of autoimmune diseases

Newly discovered drug-like compound may revolutionize treatment of autoimmune diseases

Study identifies molecular pathway critical to development of fibrosis

Study identifies molecular pathway critical to development of fibrosis

Low-energy ESWT shows promise for managing digital ulcers in patients with systemic sclerosis

Low-energy ESWT shows promise for managing digital ulcers in patients with systemic sclerosis

Targeting immune cells could lead to new treatments for pulmonary fibrosis

Targeting immune cells could lead to new treatments for pulmonary fibrosis

New tools can potentially play key role in early diagnosis of systemic sclerosis

New tools can potentially play key role in early diagnosis of systemic sclerosis

Study findings may help shed light on cause of systemic sclerosis

Study findings may help shed light on cause of systemic sclerosis

Infantile spasms and multiple sclerosis relapse data presented at AAN

Infantile spasms and multiple sclerosis relapse data presented at AAN

New research identifies mechanism that may lead to treatment of fibrosis in scleroderma

New research identifies mechanism that may lead to treatment of fibrosis in scleroderma